Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at ...

What is the current share price of Enliven Therapeutics (ELVN)? Enliven Therapeutics's (ELVN) current share price is $24.07. This constitutes a price movement of 7.60% when compared to the share price ...

Enliven Therapeutics' ELVN-001 shows promising interim data, achieving a 44% major molecular response rate in heavily pre-treated CML patients within 12 weeks. ELVN-001 targets the BCR-ABL gene ...

ELVN's initial phase 1 data for ELVN-001 in CML shows promising tolerability and activity in heavily pretreated patients, but the valuation remains high for a phase 1 company. ELVN-002 is in phase ...

Aaaaaaa Aaaa Aa 102.22 +34.00% ...

New Brand Reflects Company's Strategic Vision and Leadership in Internet Marketing Technology Solutions Market NEW YORK, Dec. 18 /PRNewswire-FirstCall/ -- Viewpoint ...